liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Cost-effectiveness Analysis of Goal-directed Hemodynamic Treatment of Elderly Hip Fracture Patients: Before Clinical Research Starts
Karolinska Institute, CLINTEC, Div of Anesthesiology.
Linköping University, Department of Medical and Health Sciences, Health Technology Assessment and Health Economics. Linköping University, Faculty of Health Sciences.
Lund University, Dept of Health Sciences.
Lund University Hospital, Dept of Orthopedics.
Show others and affiliations
2012 (English)In: Anesthesiology, ISSN 0003-3022, E-ISSN 1528-1175, Vol. 117, no 3, 519-530 p.Article in journal (Refereed) Published
Abstract [en]

Background: Health economic evaluations are increasingly used to make the decision to adopt new medical interventions. Before such decisions, various stakeholders have invested in clinical research. But health economic factors are seldom considered in research funding decisions. Cost-effectiveness analysis could be informative before the launch of clinical research projects, particularly when a targeted intervention is resource-intensive, total cost for the trial is very high, and expected gain of health benefits is uncertain. This study analyzed cost-effectiveness using a decision analytic model before initiating a large clinical research project on goal-directed hemodynamic treatment of elderly patients with hip fracture.

Methods: A probabilistic decision analytic cost-effectiveness model was developed; the model contains a decision tree for the postoperative short-term outcome and a Markov structure for long-term outcome. Clinical effect estimates, costs, health-related quality-of-life measures, and long-term survival constituted model input that was extracted from clinical trials, national databases, and surveys. Model output consisted of estimated medical care costs related to quality-adjusted life-years.

Results: In the base care analysis, goal-directed hemodynamic treatment reduced average medical care costs by €1,882 and gained 0.344 qualilty-adjusted life-years. In 96.5% of the simulations, goal-directed hemodynamic treatment is less costly and provides more quality-adjusted life-years. The results are sensitive to clinical effect size variations, although goal-directed hemodynamic treatment seems to be cost-effective even with moderate clinical effect.

Conclusion: This study demonstrates that cost-effectiveness analysis is feasible, meaningful, and recommendable before launch of costly clinical research projects.

Place, publisher, year, edition, pages
Lippincott Williams & Wilkins, 2012. Vol. 117, no 3, 519-530 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-81478DOI: 10.1097/ALN.0b013e3182655eb2ISI: 000307947700013OAI: diva2:552875

funding agencies|Stockholm County, Stockholm, Sweden|20080063: LS0801-0019|

Available from: 2012-09-17 Created: 2012-09-17 Last updated: 2014-10-29

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Davidson, ThomasCarlsson, Per
By organisation
Health Technology Assessment and Health EconomicsFaculty of Health Sciences
In the same journal
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 230 hits
ReferencesLink to record
Permanent link

Direct link